← Browse by Condition
Medical Condition

spinal muscular atrophy type 3

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06421831 Phase 1, Phase 2
Recruiting

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients

Enrollment
21 pts
Location
China
Sponsor
GeneCradle Inc
View Trial →